KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Times Interest Earned (2016 - 2025)

Emergent BioSolutions' Times Interest Earned history spans 15 years, with the latest figure at -$1.9 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 195.68% year-over-year to -$1.9; the TTM value through Dec 2025 reached $1.69, up 210.26%, while the annual FY2025 figure was $1.69, 210.26% up from the prior year.
  • Times Interest Earned reached -$1.9 in Q4 2025 per EBS's latest filing, down from $5.03 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $31.87 in Q4 2021 to a low of -$12.29 in Q3 2023.
  • Average Times Interest Earned over 5 years is -$0.32, with a median of -$1.27 recorded in 2025.
  • Peak YoY movement for Times Interest Earned: skyrocketed 904.18% in 2021, then plummeted 1284.87% in 2022.
  • A 5-year view of Times Interest Earned shows it stood at $31.87 in 2021, then plummeted by 113.56% to -$4.32 in 2022, then surged by 53.28% to -$2.02 in 2023, then skyrocketed by 68.2% to -$0.64 in 2024, then tumbled by 195.68% to -$1.9 in 2025.
  • Per Business Quant, the three most recent readings for EBS's Times Interest Earned are -$1.9 (Q4 2025), $5.03 (Q3 2025), and $0.11 (Q2 2025).